期刊文献+

替格瑞洛与氯吡格雷对急性非ST段抬高型心肌梗死患者经皮冠状动脉介入术后炎症因子的影响 被引量:98

Effect on inflammatory factors between ticagrelor and clopidogrel after PCI in acute non-ST segment elevation myocardial infarction
原文传递
导出
摘要 目的观察替格瑞洛与氯吡格雷对急性非ST段抬高型心肌梗死患者经皮冠状动脉介入(PCI)术后炎症因子的影响。方法 160例急性非ST段抬高型心肌梗死患者按术前使用抗血小板药物的不同分为试验组79例和对照组81例。试验组给予阿司匹林300 mg,替格瑞洛180 mg,以后给予阿司匹林100 mg,每天1次,替格瑞洛90 mg,每天2次;对照组给予阿司匹林300 mg,氯吡格雷600 mg,以后给予阿司匹林100 mg,每天1次,氯吡格雷75 mg,每天1次。分别测定经皮冠状动脉介入术前、术后24 h、术后7 d、术后1个月时炎症因子C-反应蛋白(CRP)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、可溶性CD40配体(sCD40L)的含量,观察2组患者不同时间点的炎症因子水平。结果与术前比较,2组CRP,IL-6,TNF-α在术后24 h,术后7 d,术后1个月均显著降低,sCD40L显著升高(P<0.05)。与对照组比较,试验组CRP、IL-6浓度在术后24 h、术后7 d、术后1个月均明显降低(P<0.05)。结论替格瑞洛较氯吡格雷能够显著降低急性非ST段抬高型心肌梗死患者PCI术后炎症因子的浓度。 Objective To investigate the clinical effect of inflammatory factors between ticagrelor and clopidogrel in acute non- ST segment elevation myocardial infarction in patients undergoing percutaneous coronary intervention( PCI). Methods A total of 160 cases of acute non- ST segment elevation myocardial infarction were divided into treatment group( n = 79) and control group( n = 81) with different antiplatelet drugs.Treatment group was orally given aspirin 300 mg and ticagrelor 180 mg,later aspirin 100 mg,qd,ticagrelor 90 mg,bid; control group orally given aspirin 300 mg and clopidogrel 600 mg,later aspirin 100 mg,qd,clopidogrel 75 mg,qd. The C- reactive protein( CRP),interleukin-6( IL- 6), tumor necrosis factor( TNF- α) and soluble CD40(sCD40L) were measured before surgery and 24 h,7 d,1 month after surgery were observed between the two groups. Results Compared with before surgery,the levels of CRP,IL- 6 and TNF- α in two group were significantly decreased,and sCD40L significantly increased 24 h,7 d,1 month after surgery( P〈0. 05). The levels of CRP,IL- 6 in treatment group were significantly lower than those in control group,with statisticallysignificance( P〈0. 05). Conclusion Compared with clopidogrel,ticagrelor can reduce the concentration of inflammatory factors in patients with acute non- ST segment elevation myocardial infarction after PCI.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2016年第9期789-791,共3页 The Chinese Journal of Clinical Pharmacology
关键词 替格瑞洛 氯吡格雷 急性非ST段抬高型心肌梗死 炎症因子 ticagrelor clopidogrel acute non ST-segment elevation myocardial infarction inflammatory factor
  • 相关文献

参考文献5

  • 1RUYGROK P N, DE JAEGERE P T, VAN DOMBURG R T, et al. Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients [ J ]. J Am Coll Cardiol, 1996, 27(7) :1669 - 1677.
  • 2无,沈卫峰,胡大一.非ST段抬高急性冠状动脉综合征诊断和治疗指南[J].中华心血管病杂志,2012,40(5):353-367. 被引量:676
  • 3蒋激扬,刘发.腺苷的抗炎作用[J].中国药理学通报,1998,14(S1):79-82. 被引量:15
  • 4XU H, STEIN B, LIANG B, Characterization of a stimulatory adeno- sine A2a receptor in adult rat ventricular myocyte [ J ]. Am J Physiol, 1996,270 (5 Pt 2):H1655- H1661.
  • 5CRONSTEIN B N, LEVIN R I, BELANOFF J, et al. Adenosine: an endogenous inhibitor of neutrophil - mediated injury to endothelial cells [J]. J Clin Invest, 1986, 78(3) :760 -770.

二级参考文献4

共引文献689

同被引文献840

引证文献98

二级引证文献447

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部